Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Leukemia 59Precursor Cell Lymphoblastic Leukemia-Lymphoma 53Lymphoma 49Burkitt Lymphoma 39Lymphoma, Large B-Cell, Diffuse 37Lymphoma, Follicular 37Myelodysplastic Syndromes 34Lymphoma, Non-Hodgkin 34Multiple Myeloma 32Leukemia, Myeloid, Acute 31Leukemia, Myeloid, Chronic-Phase 30Leukemia, Myeloid, Accelerated Phase 28Lymphoma, Large-Cell, Immunoblastic 27Leukemia, Lymphocytic, Chronic, B-Cell 27Hodgkin Disease 22Blast Crisis 22Lymphoma, Mantle-Cell 21Lymphoma, B-Cell, Marginal Zone 21Graft vs Host Disease 21Neoplasms, Plasma Cell 20Myeloproliferative Disorders 20Dendritic Cell Sarcoma, Interdigitating 20Recurrence 19Leukemia, Myelomonocytic, Chronic 17Leukemia, Biphenotypic, Acute 17Congenital Abnormalities 17Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 15Anemia, Refractory, with Excess of Blasts 15Primary Myelofibrosis 13Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 13

Interventions

pembrolizumab 23Nivolumab 22aldesleukin 21Cyclophosphamide 20Ipilimumab 17Interleukin-2 17fludarabine 15fludarabine phosphate 14cemiplimab 12Radiotherapy 7Fluorouracil 7Dacarbazine 6binimetinib 5Vemurafenib 5Temozolomide 5Surgical Procedures, Operative 5Sirolimus 5Radiation 5Biopsy 5Aminolevulinic Acid 5encorafenib 4dabrafenib 4Photochemotherapy 4Educational Status 4trametinib 3sonidegib 3montanide ISA 51 3avelumab 3Tacrolimus 3Sodium Chloride 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Skin Neoplasms × Methylprednisolone × Clear all
NCT04305145 2026-01-29

Infliximab for Treatment of Immune Checkpoint Inhibitor Colitis

Massachusetts General Hospital

Phase 2 Active not recruiting
42 enrolled
Dermatologic

Colitis, Melanoma, Skin Neoplasms, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡